Publications

Antimicrobial Susceptibility of Daptomycin and Comparator Agents Tested against Methicillin-Resistant S. aureus (MRSA) and Vancomycin-Resistant Enterococci (VRE): Analysis of a Five-Year Trend in USA Medical Centres (2005-2009), Lead author: Sader HS, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada

Mutations Associated with Ketolide Resistance in S. Pneumoniae Collected in the 2009 SENTRY Antimicrobial Surveillance Program, Lead author: Farrell DJ, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada

Experience with Linezolid in Vitro Coverage (% Susceptible) of S. aureus Pneumonia Isolates: Report From the SENTRY Antimicrobial Surveillance Program (1998-2009), Lead author: Jones RN, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada

Summary of 2009 Oxazolidinone Resistance (R) Surveillance Studies Worldwide (LEADER and ZAAPS Programs), Lead author: Jones RN, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada

Linezolid Resistance Mechanisms Among Staphylococci and Enterococci Collected From Global Resistance Surveillance Programs, Lead author: Mendes RE, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada

Tigecycline Activity against Multidrug-Resistant Enterobacteriaceae and Acinetobacter Spp. Isolated in USA Hospitals (2005-2009), Lead author: Sader HS, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada

Species Distribution and Frequency of Antifungal Resistance (R) Variations Among Candida Bloodstream Infections (BSI) Isolates by Patient Age: Report From the SENTRY Program, Lead author: Pfaller MA, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada

Candida Bloodstream Infection (CBI): Comparison of Species Distribution and Resistance to Micafungin (MCF) and Azole Antifungal Agents in Intensive Care Unit (ICU) and Non-ICU Settings, Lead author: Pfaller MA, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada

JNJ-Q2: a New Fluoroquinolone with Potent In Vitro Activity Against Staphylococcus aureus, Including Methicillin- and Fluoroquinolone-Resistant Strains, Lead author: Farrell DJ, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada

Impact Assessment of Revised CLSI Cephalosporin Breakpoints (M100-S20, 2010) Using 27,415 Enterobacteriaceae Isolates Tested in the SENTRY Antimicrobial Surveillance Program, Lead author: Rhomberg PR, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada

Ceftaroline Activity Tested against Common Organisms Causing Skin and Skin-Structure Infections in USA Medical Centers During 2009, Lead author: Sader HS, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada

Ceftaroline Activity When Tested against Respiratory Tract Infection (RTI) Pathogens Isolated From USA Medical Centers in 2009, Lead author: Sader HS, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada

Antimicrobial Activity of Ceftaroline Combined with NXL104 When Tested against Enterobacteriaceae Producing Derepressed AmpC β-Lactamase, Lead author: Sader HS, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada

Worldwide Summary of Ceftobiprole Spectrum and Activity: Potencies against Enterobacteriaceae and Non-Fermentative Gram-Negative Bacilli (59,695 Isolates), Lead author: Farrell DJ, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada

Worldwide Summary of Ceftobiprole Activity against 108,577 Gram-Positive Pathogens, Lead author: Farrell DJ, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada

Antimicrobial Activity of a New Fluoroketolide (CEM-101) Tested against Fastidious Gram-Negative Community-Acquired Bacterial Pneumonia (CABP) Pathogens, Lead author: Biedenbach DJ, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada

Antimicrobial Activity of a New Fluoroketolide (CEM-101) Tested against Streptococcus Pneumoniae Tested by the SENTRY Surveillance Program (2008-2009), Lead author: Biedenbach DJ, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada

Evaluation of Oritavancin Antimicrobial Activity Tested against Staphylococcus aureus Associated with Skin and Skin-Structure Infections (2008 – 2009), Lead author: Mendes RE, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada

Activity of Fusidic-Acid Tested against Contemporary Staphylococcus aureus Collected From United States Hospitals, Lead author: Castanheira M, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada

Epidemiologic Characterization of Carbapenemase-Producing Enterobacteriaceae in India, Lead author: Mendes RE, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada

Worldwide Summary of Doripenem Spectrum and Activity: Potencies against Non-Fermentative and Fastidious Gram-Negative Pathogens, Lead author: Farrell DJ, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada

Worldwide Summary of Doripenem Spectrum and Activity: Potencies against Enterobacteriaceae (57,724 Isolates), Lead author: Farrell DJ, presented at 48th annual Infectious Diseases Society of America (IDSA), October 21 – 24, 2010, Vancouver, Canada

Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Evaluate Susceptibility Breakpoints (SB) for Labeled Cefepime Dosing Regimens, Lead author: Van Wart, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA

Pharmacokinetic-Pharmacodynamic (PK-PD) Basis for CLSI Carbapenem (CARB) Susceptibility Breakpoint Changes, Lead author: Bhavnani SM, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA

Rare Occurrence of Retapamulin Resistance Mechanisms in Staphylococcus aureus Clinical Isolates: Report from the SENTRY Program, Lead author: Mendes RE, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA

First Report of cfr-Carrying Staphylococcal Clinical Isolates in Mexico and Evidence of In Vivo cfr Mobilization, Lead author: Mendes RE, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA

Decreased-Linezolid Susceptibility Due to cfr in a Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) Clone (USA300), Lead author: Mendes RE, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA

Genetic Characterization and Comparative Antimicrobial Susceptibility of a New bla_VIM-Variant, Lead author: Mendes RE, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA

Oxa-163, an Oxa-48-Related Class D Beta-Lactamase with an Extended Activity to Expanded-Spectrum Cephalosporins, Lead author: Poirel, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA

Mechanisms of Resistance and Antimicrobial Susceptibility Profile of Carbapenem-Resistant Acinetobacter baumanii from P.R. China, Lead author: Wang, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA

Genetic Characterization of bla_KPC-2-Carrying Klebsiella pneumoniae Collected from P.R. China During the 2009 SENTRY Antimicrobial Surveillance Program, Lead author: Wang, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA

Reduced Susceptibility to Extended-Spectrum Cephalosporins (ESC^RS) in Neisseria gonorrhoeae from Ontario, Canada, Lead author: Melano, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA

Plasmid-Borne vga(A)-Encoding Gene in Methicillin-Resistant Staphylococcus aureus (MRSA) ST-398 from Swine and Swine Farmer in the United States, Lead author: Mendes RE, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA

IS21-558 Insertion Sequences Associated with cfr Dissemination in S. epidermidis and S. aureus Recovered from two Medical Facilities in Ohio, Lead author: Mendes RE, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA

Extended-Spectrum β-Lactamases (ESBLs) and Serine Carbapenemases in Pseudomonas aeruginosa from the Asia-Pacific Region: Report from the SENTRY Surveillance Program, Lead author: Bell JM, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA

Emergence of GES-Type ESBLs in Pseudomonas aeruginosa in Indian Hospitals, Lead author: Bell JM, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA

Dissemination of NDM-1-producing Enterobacteriaceae in India, Lead author: Mendes RE, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA

Recent Antimicrobial Resistance Increases among S. pneumoniae in Four Geographic Regions: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Jones RN, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA

Comprehensive In Vitro Assessment of Oritavancin Activity Tested against S. aureus Causing Invasive Disease (2008 – 2009), Lead author: Mendes RE, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA

Activity of Oritavancin Tested against Vancomycin-Resistant Enterococci Recovered from Bacteremic Patients in USA and European Hospitals (2008 – 2009), Lead author: Mendes RE, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA

Tigecycline Activity Tested Against Rarely Recovered Gram-positive Species, Lead author: Sader HS, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA

Antimicrobial Activity of PTK 0796 Tested against Gram-positive Organisms Causing Bloodstream Infections in 2009, Lead author: Sader HS, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA

Activity of Ceftaroline/NXL104 Tested against Contemporary (2009) Clinical Isolates of Staphylococci and Streptococci Collected from USA Medical Centers, Lead author: Sader HS, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA

Worldwide Summary of Doripenem Spectrum and Activity: Potencies against 128,444 Gram-Positive Pathogens, Lead author: Farrell DJ, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA

Antimicrobial Activity of a Novel Polymyxin Analog (CB-182,804) Tested against Clinical Strains of Gram-Negative Bacilli, including Colistin-Resistant Organisms, Lead author: Sader HS, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA

Potency and Spectrum of Activity of AN3365: A Novel Boron-Containing Protein Synthesis Inhibitor Tested against Enterobacteriaceae, Lead author: Mendes RE, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA

Potency and Spectrum of Activity of AN3365, a Novel Boron-containing Protein Synthesis Inhibitor, Tested against Non-fermentative Gram-negative Bacilli, Lead author: Biedenbach DJ, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA

Activity BC-3781, a Novel Pleuromutilin Compound, Tested against Clinical Isolates of MRSA, Including Molecularly Characterized Community-Acquired and Hospital-Associated Strains, Lead author: Sader HS, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA

Antimicrobial Activity of the Investigational Pleuromutilin BC-3781 against Organisms Responsible for Community-Acquired Respiratory Tract Infections (CA-RTI), Lead author: Sader HS, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA

In Vitro Activity of MC-1: A New Gram-Negative Antimicrobial Agent, Lead author: Farrell DJ, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA